Mechanisms of Cisplatin Resistance in Triple Negative Breast Cancer
Genomic instability and deregulated proliferation are hallmarks of human tumors. Cytotoxic chemotherapeutics, including cisplatin, have been used for over forty years to combat cancers that have deregulated proliferation and alterations in DNA damage response pathways. During initial clinical invest...
Main Author: | Pendleton, Christopher Stephen |
---|---|
Other Authors: | Jennifer Pietenpol |
Format: | Others |
Language: | en |
Published: |
VANDERBILT
2014
|
Subjects: | |
Online Access: | http://etd.library.vanderbilt.edu/available/etd-11242014-103854/ |
Similar Items
-
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
by: David P. Hill, et al.
Published: (2019-11-01) -
Effect of cisplatin on triple negative breast cancer cells
by: Ahmedelnour, Hend Salaheldien
Published: (2017) -
A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer
by: Amedeo Amedei, et al.
Published: (2020-06-01) -
Analysis of Adaptive Olaparib Resistance Effects on Cisplatin Sensitivity in Triple Negative Breast Cancer Cells
by: Ambikai Gajan, et al.
Published: (2021-07-01) -
Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells
by: Madalina Andreea Badea, et al.
Published: (2018-11-01)